Pegvisomant in acromegaly: a multicenter real-life study in Argentina

Pegvisomant in acromegaly: a multicenter real-life study in Argentina

ABSTRACT Objective To describe the long term safety and efficacy of pegvisomant (PEGV), and the predictors of treatment response in patients with acromegaly in the real life setting. Subjects and methods We retrospectively reviewed the clinical, hormonal and radiological data of acromegalic pati...

Full description

Bibliographic Details
Main Authors: Natalia Ximena Garcia Basavilbaso, Maria Carolina Ballarino, Darío Bruera, Oscar D. Bruno, Alberto B. Chervin, Karina Danilowicz, Patricia Fainstein-Day, Silvina Gabriela Fidalgo, Adriana Frigeri, Mariela Glerean, Rodolfo Guelman, Gabriel Isaac, Debora Adela Katz, Pablo Knoblovits, Fabiana Librandi, Monica López Montes, Maria Susana Mallea-Gil, Marcos Manavela, Paula Mereshian, Daniel Moncet, Analia Pignatta, Amelia Rogozinsky, Laura R. Sago, Marisa Servidio, Monica Spezzi, Graciela Stalldecker, Julieta Tkatch, Nicolas Marcelo Vitale, Mirtha Guitelman
Format: Article
Language:English
Published: Brazilian Society of Endocrinology and Metabolism
Series:Archives of Endocrinology and Metabolism
Subjects:
Pegvisomant
acromegaly
GH receptor antagonist
clinical trial
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972019000700320&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972019000700320&lng=en&tlng=en

Similar Items